Molecular Imaging of Neuropsychiatry and Boron Neutron Capture Therapy in Neuro-oncology

Author(s): Chun-Kai Fang, Ya-Fang Chang, Hui-Yen Chuang, Hong-Wen Chen, Jeng-Jong Hwang

Journal Name: Current Molecular Imaging (Discontinued)

Volume 3 , Issue 1 , 2014


Both neuropsychiatric disorders and malignancies of central nervous system (CNS) represent a significant health burden and life-threatening diseases worldwide. Radiotracer-based neuroimaging is an attractive tool that permits the in vivo detection and characterization of metabolic and molecular processes which are fundamental elements for brain function, and improves the theranostics of brain diseases and disorders.

In this review, we outlined the new development of molecular imaging probes for dopamine and serotonin systems in neuropsychiatry and boron neutron capture therapy (BNCT) for brain tumors in neuro-oncology with positron emission tomography (PET) and single-photon emission computed tomography (SPECT).

Keywords: Boron neutron capture therapy, dopamine, molecular imaging, positron emission tomography, serotonin, singlephoton emission computed tomography.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 15 September, 2014
Page: [15 - 26]
Pages: 12
DOI: 10.2174/15748855113089990013

Article Metrics

PDF: 26